Bismuth subcitrate as treatment of diarrhea in fragile patients with SARS-CoV-2 infection

Med Clin (Barc). 2022 Nov 11;159(9):453-454. doi: 10.1016/j.medcli.2022.07.017. Epub 2022 Aug 11.
[Article in English, Spanish]
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19* / complications
  • Diarrhea / drug therapy
  • Diarrhea / etiology
  • Helicobacter Infections*
  • Humans
  • SARS-CoV-2

Substances

  • bismuth tripotassium dicitrate